posted on 2016-01-27, 00:00authored byM. Wang, S. LI, W. Xie, T.G.H. Diekwisch
Despite extensive research in knee and hip osteoarthritis (OA), the underlying mechanism of
temporomandibular joint (TMJ) disorder remains largely unknown. The purpose of this study was
to determine whether the constitutive activation of β-catenin in the middle and deep layers of the
articular cartilage can compromise the homeostasis of this tissue in the TMJ. Co12CreERT2
transgenic mice were bred with RosamT/mG reporter mice to determine Cre recombination
efficiency. Co12CreERT2 mice were then crossed with β-cateninflox (ex3)/+ mice to generate β-
catenin conditional activation mice, β-catenin(ex3)
Co12ER. TMJ samples were harvested when the
mice were 1-, 3- or 6-month-old and evaluated using histology, histomorphometry and
immunohistochemistry. β-catenin(ex3)
Co12ER mice were further crossed with Mmp13flox/flox and
Adamts5−/− mice to generate β-catenin(ex3)/Mmp13)
Co12ER and β-catenin(ex3)
Co12ER)/Adamts5−/−
double mutant mice to investigate the role of Mmp13 and Adamts5 in the development of TMJ
disorder. High levels of Cre-recombination were seen in Co12CreERT2;RosamT/mG mice.
Progressive TMJ defects developed in 1-, 3- and 6-month-old β-catenin(ex3)
Co12ER mice, as
revealed by histology and histomorphometry. Results further demonstrated that the defects
observed in β-catenin(ex3)
Co12ER mice were significantly decelerated after deletion of the Mmp13
or Adamts5 gene in (β-catenin(ex3)/Mmp13)
co12ER or β-catenin(ex3)
Co12ER/ Adamts5−/− double
mutant mice. In summary, we found that β-catenin is a critical gene in the induction of TMJ
cartilage degeneration, and over-expressing β-catenin in TMJ cartilage leads to defects assembling
an OA-like phenotype. Deletion of Mmp13 and Adamts5 in β-catenin(ex3)
Co12ER mice ameliorates the development of TMJ defects. This study suggests that Mmp13 and Adamts5 could be potential
therapeutic targets for the treatment of TMJ disorders
Funding
This work was supported by Grants R01 AR055915 and R01 AR054465 to D.C. from the National Institutes of
Health. The authors thank Verhonda Hearon-Eggleston for assistance in preparing the manuscript. The authors
declare that no competing interests exist, and that the funders had no role in study design, data collection and
analysis, decision to publish, or preparation of the manuscript.